Financial Gravity Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39K | Buy |
231
+1
| +0.4% | +$171 | 0.01% | 337 |
|
|
2025
Q4 | $38.8K | Hold |
230
| – | – | 0.01% | 277 |
|
|
2025
Q3 | $33.2K | Buy |
+230
| New | +$31.4K | 0.01% | 347 |
|
|
2025
Q1 | $30.2K | Buy |
+236
| New | +$32K | 0.01% | 406 |
|
|
2024
Q2 | – | Sell |
-54
| Closed | -$7.36K | – | 1958 |
|
|
2024
Q1 | $7.36K | Buy |
+54
| New | +$7.38K | ﹤0.01% | 787 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1429 |
|
|
2023
Q3 | – | Sell |
-127
| Closed | -$16.2K | – | 1164 |
|
|
2023
Q2 | $10.1K | Buy |
+127
| New | +$16.5K | 0.03% | 335 |
|
|
2023
Q1 | – | Sell |
-131
| Closed | -$7.71K | – | 1380 |
|
|
2022
Q4 | $7.71K | Sell |
131
-1,741
| -93% | -$225K | 0.04% | 331 |
|
|
2022
Q3 | $22.6K | Sell |
1,872
-252
| -12% | -$31.3K | 0.76% | 29 |
|
|
2022
Q2 | $47.9K | Sell |
2,124
-216
| -9% | -$25.6K | 1.49% | 12 |
|
|
2022
Q1 | $28.1K | Buy |
+2,340
| New | +$305K | 0.79% | 29 |
|
|
2020
Q2 | – | Sell |
-904
| Closed | -$97.3K | – | 409 |
|
|
2020
Q1 | $97.3K | Buy |
+904
| New | +$104K | 0.3% | 37 |
|
|
2019
Q4 | – | Sell |
-7
| Closed | -$1K | – | 1549 |
|
|
2019
Q3 | $1K | Buy |
7
+1
| +17% | +$105 | ﹤0.01% | 1040 |
|
|
2019
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 1061 |
|
|
2019
Q1 | $1K | Buy |
+6
| New | +$658 | ﹤0.01% | 1115 |
|
|
2018
Q3 | $2K | Hold |
17
| – | – | ﹤0.01% | 969 |
|
|
2018
Q2 | $2K | Sell |
17
-137
| -89% | -$14.7K | ﹤0.01% | 996 |
|
|
2018
Q1 | $16K | Buy |
+154
| New | +$17.1K | 0.02% | 525 |
|
Other funds holding IBB
CB
